Last reviewed · How we verify
NCT03947801
Dairy Consumption During a High-intensity, High-volume Training Week in Young Athletes
NA trial testing Greek Yogurt in Inflammatory Response in 30 participants. Completed in 23 November 2019.
23 November 2019
Quick facts
| Lead sponsor | Brock University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | other |
| Enrollment | 30 |
| Start date | 1 July 2019 |
| Primary completion | 23 November 2019 |
| Estimated completion | 23 November 2019 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Greek Yogurt
- Isoenergetic carbohydrate
Conditions studied
- Inflammatory Response — all drugs for Inflammatory Response →
- Sports Performance — all drugs for Sports Performance →
Sponsor
Brock University
Who can join
Adults 11 to 16, any sex, with Inflammatory Response or Sports Performance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Our proposed study is a 5-d double-blind randomised cross-over trial, seeking to simulate a training identification camp in competitive adolescent soccer players The purpose of the proposed study is to investigate whether increased protein consumption by Greek yogurt, compared to an isoenergetic carbohydrate (CHO) control supplement, consumed immediately following exercise training, prior to sleep and between breakfast and lunch, for a week during an intense training period (high volume, high intensity) will: * Attenuate the pro-inflammatory response (cytokines, acute phase proteins) * Reduced the severity of muscle damage and impairment (creatine kinase) * Maintain performance Secondary outcome measures: \- Increase bone turnover (in favour of formation)
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Intensified training in adolescent female athletes: a crossover study of Greek yogurt effects on indices of recovery.
McKinlay BJ, Wallace PJ, Olansky S, Woods S, et al · · 2022 · cited 10× · PMID 35599913 · DOI 10.1080/15502783.2022.2044732 -
Circulating Levels of Bone Markers after Short-Term Intense Training with Increased Dairy Consumption in Adolescent Female Athletes.
Klentrou P, McKee K, McKinlay BJ, Kurgan N, et al · · 2021 · cited 5× · PMID 34828674 · DOI 10.3390/children8110961
Verify or expand the search:
- PubMed search for NCT03947801
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Greek Yogurt
Trials testing the same drug.
- NCT07513987 — IMPACT: Immune and Musculoskeletal Physiological Adaptations to Combined Exercise Training & Nutrition · NA · not yet recruiting
Other recruiting trials for Inflammatory Response
Currently open trials in the same condition.
- NCT06450704 — Cerebral and Anti-inflammatory Response Through Exercise - Mechanisms In Depressive Disorders · NA · recruiting
- NCT06519487 — Social Experiences and Demographic Factors in the Regulation of Immune Cells · NA · recruiting
- NCT06434701 — Severe COVID-19 Infection in Children Presenting to EDs in Israel and England · NA · recruiting
- NCT06491966 — Clinical Outcomes and Inflammatory Responses in Viral vs. Bacterial Sepsis · recruiting
- NCT06342024 — Pistachio Consumption on Inflammatory Markers and Lean Body Mass · NA · active not recruiting
Other Brock University trials
Trials by the same sponsor.
- NCT04345250 — Bone Response to Exercise and Energy Restriction in Young Adults · NA · suspended
- NCT06530394 — Effects of Increased Greek Yogurt Consumption in Senior Adults · NA · completed
- NCT04670133 — Inulin Supplementation During Sanative Therapy to Further Improve Periodontal Healing · NA · withdrawn
- NCT04380155 — Cycling Duration and Bone Markers in in Active Young Adults · NA · withdrawn
- NCT05922462 — Effects of Increased Greek Yogurt Consumption in Youth and Young Adult Athletes · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03947801 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Brock University
- Last refreshed: 2 June 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03947801.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing